Daniel J. Lippis - 10 Jul 2026 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Reporting relationship: CVP, TAVR
Issuer ticker: EW
Reported as of: 10 Jul 2026
Net transaction value: -$56,762
SEC form: 4
Accepted by SEC: 10 Jul 2026, 17:04:11 UTC
Prior SEC filing: 07 Jul 2026
Source filing: View source filing
Reporting owner signature: Linda J. Park, Attorney-in-Fact

Key filing fact

Daniel J. Lippis filed Form 4 for Edwards Lifesciences Corp (EW) on 10 Jul 2026.

Key facts

This page summarizes Daniel J. Lippis's Form 4 filing for Edwards Lifesciences Corp (EW).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 10 Jul 2026, 17:04.

Change

Previous filing in this sequence was filed on 07 Jul 2026.
Current net transaction value: -$56,762.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002004380 Primary reporting owner

Lippis Daniel J.

Relationship: CVP, TAVR
Address: ONE EDWARDS WAY, IRVINE
Signature: Linda J. Park, Attorney-in-Fact
Signature date: 10 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EW transaction

Common Stock

Options Exercise

Transaction value
Shares: +619
Change %: +1.5%
Price: $72.68^*
Shares after: 40,653
Date: 10 Jul 2026
Ownership: Direct
Footnotes: F1

EW transaction

Common Stock

Sale

Transaction value: $56,762
Shares: -619
Change %: -1.5%
Price: $91.70
Shares after: 40,034
Date: 10 Jul 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EW transaction Derivative

Employee Stock Option (Right to Acquire)

Options Exercise

Transaction value
Shares: -619
Change %: -11%
Price: $0.000000^*
Shares after: 4,952
Date: 10 Jul 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 619
Exercise price: $72.68

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 1 footnote

Footnote F1

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026.

SEC remarks

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.